Anacor-302: A Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study of the Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis

Project: Research project

Project Details

StatusFinished
Effective start/end date6/17/146/30/16

Funding

  • Northwestern University (Anacor-302)
  • Anacor Pharmaceuticals, Inc. (Anacor-302)